Evidence map›Paper›PMID 19307586›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Single-round selection yields a unique retroviral envelope utilizing GPR172A as its host receptor.

Peter M Mazari, Daniela Linder-Basso, Anindita Sarangi, Yehchung Chang, Monica J Roth

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Peter M MazariUniversity of Medicine and Dentistry of New Jersey-The Robert Wood Johnson Medical School, Department of Biochemistry, Piscataway, NJ 08854, USA.
Daniela Linder-Basso
Anindita Sarangi
Yehchung Chang
Monica J Roth
Rutgers, The State University of New Jersey · US

Funding

THE ENVELOPE GENE PRODUCTS OF MURINE LEUKEMIA VIRUSR01CA049932 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ROTH, MONICA J. · 1990 to 2011
$3.0M
NCI NIH HHS 1R01CA49932NCI NIH HHS R01 CA049932
6 · The paper itself

Abstract

The recognition by a viral envelope of its cognate host-cell receptor is the initial critical step in defining the viral host-range and tissue specificity. This study combines a single-round of selection of a random envelope library with a parallel cDNA screen for receptor function to identify a distinct retroviral envelope/receptor pair. The 11-aa targeting domain of the modified feline leukemia virus envelope consists of a constrained peptide. Critical to the binding of the constrained peptide envelope to its cellular receptor are a pair of internal cysteines and an essential Trp required for maintenance of titers >10(5) lacZ staining units per milliliter. The receptor used for viral entry is the human GPR172A protein, a G-protein-coupled receptor isolated from osteosarcoma cells. The ability to generate unique envelopes capable of using tissue- or disease-specific receptors marks an advance in the development of efficient gene-therapy vectors.

Indexed as

Amino Acid SequenceBinding SitesLeukemia Virus, FelineOsteosarcomaPeptide FragmentsReceptors, G-Protein-CoupledReceptors, VirusViral Envelope ProteinsPeptide FragmentsReceptors, G-Protein-CoupledReceptors, VirusSLC52A2 protein, humanViral Envelope Proteins

Identifiers

PMID19307586
PMCPMC2667028
OpenAlexW2014287680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.